Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Use and acceptance of electronic communication by patients with multiple sclerosis: a multicenter questionnaire study.
Endovascular Treatment of Chronic Cerebro-Spinal Venous Insufficiency in Multiple Sclerosis: A retrospective study.
Compromised motor imagery ability in individuals with multiple sclerosis and mild physical disability: An ERP study.
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
The multiple sclerosis drug fingolimod (FTY720) stimulates neuronal gene expression, axonal growth and regeneration.
[New and emerging treatments for multiple sclerosis].
Opexa Therapeutics provides MS trial enrollment update; 70% of patients enrolled
Restless legs syndrome and multiple sclerosis: a population based case-control study in Catania, Sicily.
Efficacy and Side Effects of Natalizumab Therapy in Patients with Multiple Sclerosis.
Can the irradiated brain be salvaged by oligodendrocyte precursor transplantation?
Modulation of Glutamate Transport and Receptor Binding by Glutamate Receptor Antagonists in EAE Rat Brain.
A personalized, intense physical rehabilitation program improves walking in people with multiple sclerosis presenting with different levels of disability: a retrospective cohort.
Switch-associated protein 70 antibodies in multiple sclerosis: relationship between increased serum levels and clinical relapse.
Misoprostol as a Therapeutic Option for Trigeminal Neuralgia in Patients with Multiple Sclerosis.
Role of Vitamin D in the Onset, Progression and Severity of Multiple Sclerosis.
Cognitive impairment is correlated with reduced quality of life in patients with clinically isolated syndrome.
Novel Marmoset (Callithrix jacchus) Model of Human Herpesvirus 6A and 6B Infections: Immunologic, Virologic and Radiologic Characterization.
Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses.
Community Delivery of a Comprehensive Fall-Prevention Program in People with Multiple Sclerosis: A Retrospective Observational Study.
Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients.
How microglia kill neurons.
Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.
Multiple sclerosis: Brain volume loss strengthens disease measure.
Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS.
Autoimmune disease: A role for new anti-viral therapies?
Pages
« first
‹ previous
…
333
334
335
336
337
338
339
340
341
…
next ›
last »